These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 34120579)

  • 1. Prior aerosol infection with lineage A SARS-CoV-2 variant protects hamsters from disease, but not reinfection with B.1.351 SARS-CoV-2 variant.
    Yinda CK; Port JR; Bushmaker T; Fischer RJ; Schulz JE; Holbrook MG; Shaia C; de Wit E; van Doremalen N; Munster VJ
    Emerg Microbes Infect; 2021 Dec; 10(1):1284-1292. PubMed ID: 34120579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 infection induces protective immunity and limits transmission in Syrian hamsters.
    Selvaraj P; Lien CZ; Liu S; Stauft CB; Nunez IA; Hernandez M; Nimako E; Ortega MA; Starost MF; Dennis JU; Wang TT
    Life Sci Alliance; 2021 Apr; 4(4):. PubMed ID: 33574037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster.
    Brustolin M; Rodon J; Rodríguez de la Concepción ML; Ávila-Nieto C; Cantero G; Pérez M; Te N; Noguera-Julián M; Guallar V; Valencia A; Roca N; Izquierdo-Useros N; Blanco J; Clotet B; Bensaid A; Carrillo J; Vergara-Alert J; Segalés J
    Emerg Microbes Infect; 2021 Dec; 10(1):797-809. PubMed ID: 33825619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of SARS-CoV-2 Variants of Concern 202012/01 (U.K. Variant) and D614G Variant Transmission by Different Routes in Syrian Hamsters.
    Mohandas S; Yadav PD; Nyayanit D; Shete A; Sarkale P; Hundekar S; Kumar S; Lole K
    Vector Borne Zoonotic Dis; 2021 Aug; 21(8):638-641. PubMed ID: 34197265
    [No Abstract]   [Full Text] [Related]  

  • 5. Transmission and Protection against Reinfection in the Ferret Model with the SARS-CoV-2 USA-WA1/2020 Reference Isolate.
    Patel DR; Field CJ; Septer KM; Sim DG; Jones MJ; Heinly TA; Vanderford TH; McGraw EA; Sutton TC
    J Virol; 2021 Jun; 95(13):e0223220. PubMed ID: 33827954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex Differences in Lung Imaging and SARS-CoV-2 Antibody Responses in a COVID-19 Golden Syrian Hamster Model.
    Dhakal S; Ruiz-Bedoya CA; Zhou R; Creisher PS; Villano JS; Littlefield K; Ruelas Castillo J; Marinho P; Jedlicka AE; Ordonez AA; Bahr M; Majewska N; Betenbaugh MJ; Flavahan K; Mueller ARL; Looney MM; Quijada D; Mota F; Beck SE; Brockhurst J; Braxton AM; Castell N; Stover M; D'Alessio FR; Metcalf Pate KA; Karakousis PC; Mankowski JL; Pekosz A; Jain SK; Klein SL;
    mBio; 2021 Aug; 12(4):e0097421. PubMed ID: 34253053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective Immunity of the Primary SARS-CoV-2 Infection Reduces Disease Severity Post Re-Infection with Delta Variants in Syrian Hamsters.
    Mohandas S; Yadav PD; Shete A; Nyayanit D; Jain R; Sapkal G; Mote C
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35337002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical role of neutralizing antibody for SARS-CoV-2 reinfection and transmission.
    Kim YI; Kim SM; Park SJ; Kim EH; Yu KM; Chang JH; Kim EJ; Casel MAB; Rollon R; Jang SG; Um J; Song MS; Jeong HW; Kim EG; Kim Y; Kim SY; Park JS; Park MS; Kwon GY; Yeo SG; Lee SA; Choi YJ; Jung JU; Choi YK
    Emerg Microbes Infect; 2021 Dec; 10(1):152-160. PubMed ID: 33407005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 reinfection prevents acute respiratory disease in Syrian hamsters but not replication in the upper respiratory tract.
    Hansen F; Meade-White K; Clancy C; Rosenke R; Okumura A; Hawman DW; Feldmann F; Kaza B; Jarvis MA; Rosenke K; Feldmann H
    Cell Rep; 2022 Mar; 38(11):110515. PubMed ID: 35263638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 disease severity and transmission efficiency is increased for airborne compared to fomite exposure in Syrian hamsters.
    Port JR; Yinda CK; Owusu IO; Holbrook M; Fischer R; Bushmaker T; Avanzato VA; Schulz JE; Martens C; van Doremalen N; Clancy CS; Munster VJ
    Nat Commun; 2021 Aug; 12(1):4985. PubMed ID: 34404778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune memory from SARS-CoV-2 infection in hamsters provides variant-independent protection but still allows virus transmission.
    Horiuchi S; Oishi K; Carrau L; Frere J; Møller R; Panis M; tenOever BR
    Sci Immunol; 2021 Dec; 6(66):eabm3131. PubMed ID: 34699266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental re-infected cats do not transmit SARS-CoV-2.
    Gaudreault NN; Carossino M; Morozov I; Trujillo JD; Meekins DA; Madden DW; Cool K; Artiaga BL; McDowell C; Bold D; Balaraman V; Kwon T; Ma W; Henningson J; Wilson DW; Wilson WC; Balasuriya UBR; García-Sastre A; Richt JA
    Emerg Microbes Infect; 2021 Dec; 10(1):638-650. PubMed ID: 33704016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term, infection-acquired immunity against the SARS-CoV-2 Delta variant in a hamster model.
    Halfmann PJ; Kuroda M; Armbrust T; Accola M; Valdez R; Kowalski-Dobson T; Rehrauer W; Gordon A; Kawaoka Y
    Cell Rep; 2022 Feb; 38(7):110394. PubMed ID: 35139368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model.
    O'Donnell KL; Pinski AN; Clancy CS; Gourdine T; Shifflett K; Fletcher P; Messaoudi I; Marzi A
    EBioMedicine; 2021 Nov; 73():103675. PubMed ID: 34758415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters.
    Shiwa-Sudo N; Sakai Y; Iwata-Yoshikawa N; Watanabe S; Yamada S; Kuroda Y; Yamamoto T; Shirakura M; Fujisaki S; Miyazaki K; Miura H; Nagata S; Fukushi S; Maeda K; Hasegawa H; Suzuki T; Nagata N
    J Virol; 2023 Jan; 97(1):e0136622. PubMed ID: 36633406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralizing Monoclonal Antibodies That Target the Spike Receptor Binding Domain Confer Fc Receptor-Independent Protection against SARS-CoV-2 Infection in Syrian Hamsters.
    Su W; Sia SF; Schmitz AJ; Bricker TL; Starr TN; Greaney AJ; Turner JS; Mohammed BM; Liu Z; Choy KT; Darling TL; Joshi A; Cheng KM; Wong AYL; Harastani HH; Nicholls JM; Whelan SPJ; Bloom JD; Yen HL; Ellebedy AH; Boon ACM
    mBio; 2021 Oct; 12(5):e0239521. PubMed ID: 34517754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased small particle aerosol transmission of B.1.1.7 compared with SARS-CoV-2 lineage A in vivo.
    Port JR; Yinda CK; Avanzato VA; Schulz JE; Holbrook MG; van Doremalen N; Shaia C; Fischer RJ; Munster VJ
    Nat Microbiol; 2022 Feb; 7(2):213-223. PubMed ID: 35017676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cold-adapted SARS-CoV-2 variants with different temperature sensitivity exhibit an attenuated phenotype and confer protective immunity.
    Faizuloev E; Gracheva A; Korchevaya E; Smirnova D; Samoilikov R; Pankratov A; Trunova G; Khokhlova V; Ammour Y; Petrusha O; Poromov A; Leneva I; Svitich O; Zverev V
    Vaccine; 2023 Jan; 41(4):892-902. PubMed ID: 36528447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern.
    Mohandas S; Yadav PD; Sapkal G; Shete AM; Deshpande G; Nyayanit DA; Patil D; Kadam M; Kumar A; Mote C; Jain R
    EBioMedicine; 2022 May; 79():103997. PubMed ID: 35405385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.
    Jalkanen P; Kolehmainen P; Häkkinen HK; Huttunen M; Tähtinen PA; Lundberg R; Maljanen S; Reinholm A; Tauriainen S; Pakkanen SH; Levonen I; Nousiainen A; Miller T; Välimaa H; Ivaska L; Pasternack A; Naves R; Ritvos O; Österlund P; Kuivanen S; Smura T; Hepojoki J; Vapalahti O; Lempainen J; Kakkola L; Kantele A; Julkunen I
    Nat Commun; 2021 Jun; 12(1):3991. PubMed ID: 34183681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.